Opposite effects of chronic HIV infection and antiretroviral medication on organismal and organ-specific biological aging
Year: 2026
Type: article
Study design: Observational Study
Abstract: People with HIV (PWH) on combination antiretroviral therapy have an elevated risk for aging-related non-AIDS comorbidities. We assessed whether HIV infection accelerates biological aging in two independent cohorts of PWH using six organ-specific and three organism-wide aging clocks derived from plasma proteomics of healthy individuals. Proteomic age acceleration significantly correlated with DNA methylation age and was linked to comorbidities and mortality. HIV infection accelerated systemic biological aging, with Mendelian randomization demonstrating causality between organ aging and inflammatory or metabolic complications. Accelerated aging in PWH was further related to the total HIV reservoir, and specific antiretroviral drugs decreased age acceleration. These data reveal important causal effects between chronic HIV infection, antiretroviral medication, biological aging and age-associated diseases, highlighting targets for improving health span in PWH.
Source: Nature Communications
Authors: Yubo Zhang, Vasiliki Matzaraki, Nadira Vadaq, Marc J. T. Blaauw, Wilhelm Vos, Albert Groenendijk, Louise van Eekeren, Janneke Stalenhoef, Marvin AH Berrevoets, Casper Rokx, Mareva Delporte, Twan Otten, Leo A. B. Joosten, Cheng-Jian Xu, Yang Li, Linos Vandekerckhove, Andre van der Ven, Mihai G. Netea
Institutions: Radboud University Medical Center, OLVG, Erasmus MC, Erasmus University Rotterdam, Elisabeth-TweeSteden Ziekenhuis, Ghent University Hospital, Ghent University, Iuliu Hațieganu University of Medicine and Pharmacy, Medizinische Hochschule Hannover, Helmholtz Centre for Infection Research, Centre for Individualised Infection Medicine, Center for Experimental and Clinical Infection Research, Radboud University Nijmegen, University of Bonn
Language: English
Subfield: Emergency Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $6,990
Funder: ViiV Healthcare
OpenAlex ID: W7128475817
